Global Proteomics Market Size, Share, Opportunities, And Trends By Technology (Microarrays, Spectroscopy, X-Ray Crystallography, Chromatography, Others), By Reagents (Microarrays, Spectroscopy, X-Ray Crystallography, Chromatography, Other), By Application (Discovery of Protein Biomarkers, Study of Tumor Metastasis, Neurotrauma and Neurology, Renal Disease Diagnosis, Fetal and Maternal Medicine, Others), And By Geography - Forecasts From 2025 To 2030

Description

Proteomics Market Size:

The global proteomics market is expected to grow from USD 36.720 billion in 2025 to USD 57.582 billion in 2030, at a CAGR of 9.42%.

Proteomics is the study of the protein components in an organism. Proteomics involves the large-scale study of proteins, their role, functions, properties, and structure. In other words, proteomics is the entire dataset of the proteins produced by the living organism.  However, the proteome is not constant and differs from cell to cell and changes over time. Proteomics provides significant biological information for various problems such as proteins interacting with a particular protein of interest, proteins localized to the subcellular compartment, and proteins involved in various biological processes.

Proteomics Market Driver:

• Advancements in technologies driving the market for proteomics

Various advancements in the technologies have led to the growth of the proteomics market during the given time frame. These developments have included advances in mass spectrometry (MS) technology, protein fractionation techniques, bioinformatics, etc. Dual mass analyzers such as LC/MS, GC/MS, FT-MS, and MALDI-TOF/TOF help to provide more detailed information about protein structure. Advances in technology have led thousands of proteins to be resolved in a single gel. Apart from technological advancements, rising investments in R&D and rising demand for personalized medicine will further boost the market for proteomics. However, a lack of a skilled workforce coupled with the high instrument and training costs may restrain the market during the forecast period.

Proteomics Market Geographical Outlook:

• North America to hold a major share in proteomics markets

Geographically, North America is estimated to hold the major share of the market owing to the rapid adoption of advanced technologies. Moreover, sophisticated healthcare infrastructure coupled with the rising interest in personalized medicines will also boost the market in the region during the given projected period. The Asia Pacific is expected to be the fastest-growing region. The growth is attributed to rising government funding for proteomics research in the region.

Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining a faster and more efficient understanding of the global proteomics market.

Major industry players profiled as part of the report are Proteomics International, Biognosys AG, and Creative Proteomics (Division of Creative Dynamics Inc) among others.

Segmentation:

• By Technology
  • Microarrays
  • Spectroscopy
  • X-Ray Crystallography
  • Chromatography
  • Others
• By Component
  • Reagents & Kits
  • Consumables
  • Others
• By Reagents
  • Microarrays Reagents
  • Spectroscopy Reagents
  • X-Ray Crystallography Reagents
  • Chromatography Reagents
  • Other Reagents
• By Application
  • Discovery of Protein Biomarkers
  • Study of Tumor Metastasis
  • Neurotrauma and Neurology
  • Renal Disease Diagnosis
  • Fetal and Maternal Medicine
  • Others
• By Geography
  • NorthAmerica
    • United States
    • Canada
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • United Kingdom
    • Germany
    • France
    • Others
  • Middle East and Africa
    • Israel
    • UAE
    • Saudi Arabia
    • Others
  • Asia Pacific
    • China
    • India
    • Australia
    • South Korea
    • Others

Table Of Contents

1. EXECUTIVE SUMMARY 

2. MARKET SNAPSHOT

2.1. Market Overview

2.2. Market Definition

2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE 

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities 

3.4. Porter’s Five Forces Analysis

3.5. Industry Value Chain Analysis

3.6. Policies and Regulations 

3.7. Strategic Recommendations 

4. TECHNOLOGICAL OUTLOOK 

5. GLOBAL PROTEOMICS MARKET BY TECHNOLOGY

5.1. Introduction

5.2. Microarrays

5.3. Spectroscopy

5.4. X-Ray Crystallography

5.5. Chromatography

5.6. Others

6. GLOBAL PROTEOMICS MARKET BY COMPONENT

6.1. Introduction

6.2. Reagents & Kits

6.3. Consumables

6.4. Others

7. GLOBAL PROTEOMICS MARKET BY REAGENTS

7.1. Introduction

7.2. Microarrays Reagents

7.3. Spectroscopy Reagents

7.4. X-Ray Crystallography Reagents

7.5. Chromatography Reagents

7.6. Other Reagents

8. GLOBAL PROTEOMICS MARKET BY APPLICATION

8.1. Introduction

8.2. Discovery of Protein Biomarkers

8.3. Study of Tumor Metastasis

8.4. Neurotrauma and Neurology

8.5. Renal Disease Diagnosis

8.6. Fetal and Maternal Medicine

8.7. Others

9. GLOBAL PROTEOMICS MARKET BY GEOGRAPHY

9.1. Introduction

9.2. North America

9.2.1. United States

9.2.2. Canada

9.2.3. Mexico

9.3. South America

9.3.1. Brazil 

9.3.2. Argentina

9.3.3. Others

9.4. Europe

9.4.1. Germany

9.4.2. France

9.4.3. United Kingdom

9.4.4. Others

9.5. Middle East & Africa

9.5.1. Saudi Arabia

9.5.2. UAE

9.5.3. Others

9.6. Asia Pacific

9.6.1. China

9.6.2. Japan 

9.6.3. South Korea

9.6.4. India

9.6.5. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

10.1. Major Players and Strategy Analysis

10.2. Market Share Analysis

10.3. Mergers, Acquisitions, Agreements, and Collaborations

10.4. Competitive Dashboard

11. COMPANY PROFILES

11.1. Biognosys AG

11.2. Creative Proteomics (Division of Creative Dynamics Inc)

11.3. Proteomics International

11.4. MRM Proteomics

11.5. Evotec AG

11.6. Proteome Factory

11.7. DC Biosciences

11.8. AYOXXA Biosystems GmbH

11.9. VProteomics

11.10. Thermo Fisher Scientific

11.11. Agilent Technologies

12. APPENDIX

12.1. Currency 

12.2. Assumptions

12.3. Base and Forecast Years Timeline

12.4. Key benefits for the stakeholders

12.5. Research Methodology 

12.6. Abbreviations 

LIST OF FIGURES

LIST OF TABLES

Companies Profiled

Biognosys AG

Creative Proteomics (Division of Creative Dynamics Inc)

Proteomics International

MRM Proteomics

Evotec AG

Proteome Factory

DC Biosciences

AYOXXA Biosystems GmbH

VProteomics

Thermo Fisher Scientific

Agilent Technologies

Related Reports